Foreword: Prevention of COVID-19, Influenza, and Respiratory Syncytial Virus in At-Risk Populations

Foreword: Prevention of COVID-19, Influenza, and Respiratory Syncytial Virus in At-Risk Populations

Saved in:

Bibliographic Details
Main Author:	Stefan Gravenstein
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2024-12-01
Series:	Infectious Diseases and Therapy
Subjects:	Respiratory viruses SARS-CoV-2 Respiratory syncytial virus COVID-19 Influenza Vaccines
Online Access:	https://doi.org/10.1007/s40121-024-01078-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review
by: Roberto Debbag, et al.
Published: (2024-12-01)

Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review
by: William P. Hanage, et al.
Published: (2024-12-01)

Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations
by: Stefania Maggi, et al.
Published: (2024-12-01)

Clinical performance of two commercially available rapid antigen tests for influenza, RSV, and SARS-CoV-2 diagnostics
by: Laura E. Savolainen, et al.
Published: (2025-01-01)

Key Insights into Respiratory Virus Testing: Sensitivity and Clinical Implications
by: Julio Garcia-Rodriguez, et al.
Published: (2025-01-01)

Recommendation for the use of respiratory syncytial virus vaccines
by: Ping-Ing Lee, et al.
Published: (2025-02-01)

Circulation of Respiratory Syncytial Virus (RSV) in Poland Between Seasons of 2009/2010 and 2022/2023 Based on SENTINEL System
by: Karol Szymański, et al.
Published: (2025-01-01)

A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection
by: Angela Branche, et al.
Published: (2024-12-01)

Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant
by: Teresa Jackowska, et al.
Published: (2024-12-01)

Role of bovine respiratory syncytial virus in etiology of respiratory diseases on milk farms
by: S. V. Koteneva, et al.
Published: (2021-03-01)

Hospitalizations for bronchiolitis among infants before and after the SARS-CoV-2 pandemic: an area-based study of the Emilia-Romagna Region, Italy
by: Elisa Ballardini, et al.
Published: (2025-02-01)

Prevalence of Respiratory Syncytial Virus Infection in Hospitalized COPD Patients in Spain Between 2018–2022
by: Rosa María Gómez-García, et al.
Published: (2025-01-01)

Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01)

Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice
by: Zhuang Shihao, et al.
Published: (2022-09-01)

Optimization of cultivation parameters for bovine respiratory syncytial virus strain Vologda/2019
by: V. V. Kirpichenko, et al.
Published: (2020-09-01)

CULTURAL PROPERTIES OF BOVINE RESPIRATORY SYNCYTIAL VIRUS STRAIN AB1908
by: V. V. Kirpichenko, et al.
Published: (2019-12-01)

Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy
by: Andrea Marcellusi, et al.
Published: (2025-01-01)

Understanding the local-level variations in seasonality of human respiratory syncytial virus infection: a systematic analysis
by: Sheng Ye, et al.
Published: (2025-01-01)

Clinical manifestations, para-clinical features and outcome of Iranian adults with respiratory syncytial virus (RSV) infection: a report from hospitalized patients
by: Maryam Shafaati, et al.
Published: (2025-02-01)

Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine
by: Tiago Alfaro, et al.
Published: (2025-12-01)

Cost-savings and health impact of strategies for prevention of Respiratory Syncytial Virus with nirsevimab in Chile based on the integrated analysis of 2019–2023 national databases: A retrospective study
by: Denis Sauré, et al.
Published: (2025-04-01)

Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus
by: Xuchang Shan, et al.
Published: (2025-01-01)

Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
by: Catherine A. Panozzo, et al.
Published: (2024-11-01)

Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico
by: José Luis Huerta, et al.
Published: (2025-01-01)

Impact of COVID-19 pandemic restrictions and relaxation on pediatric respiratory virus hospitalizations in Southwest China: a retrospective study
by: Ting Gong, et al.
Published: (2025-01-01)

Co-infection of SARS‐CoV‐2 and influenza A/B among patients with COVID-19: a systematic review and meta-analysis
by: Monireh Golpour, et al.
Published: (2025-01-01)

Characterization of serum metabolome and respiratory microbiota in children with influenza A virus infection
by: Xinyi Shi, et al.
Published: (2025-01-01)

Is a Consensus Case Definition for Viral Associated Lower Respiratory Tract Disease (LRTD) in Clinical Trials Possible?
by: S. Elizabeth Williams, et al.
Published: (2024-12-01)

Estimating the prevalence of six common respiratory viral infections in Zhangzhou, China using nasopharyngeal swabs in adults and throat swabs in Children
by: Yuanjun Zeng, et al.
Published: (2025-01-01)

Acceptance and safety of the RSV-preventive treatment of newborns with nirsevimab in the maternity department: a prospective longitudinal cohort study in FranceResearch in context
by: Charlotte Ocana de Sentuary, et al.
Published: (2025-01-01)

Favorable Nonclinical Safety Profile of RSVpreF Bivalent Vaccine in Rats and Rabbits
by: Jun Zhou, et al.
Published: (2024-12-01)

Comparison of characteristics and immune responses between paired human nasal and bronchial epithelial organoids
by: Lu Zhu, et al.
Published: (2025-02-01)

Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice
by: Mariia V. Sergeeva, et al.
Published: (2024-12-01)

Hospital-Based Surveillance of Respiratory Viruses Among Children Under Five Years of Age with ARI and SARI in Eastern UP, India
by: Hirawati Deval, et al.
Published: (2024-12-01)

Face Masks and Prevention of Respiratory Viral Infections: An Overview
by: Chiu-Sen Wang
Published: (2022-12-01)

Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus
by: Shreya Mukhopadhyay, et al.
Published: (2025-01-01)

The Saudi thoracic society guidelines for vaccinations in adult patients with chronic respiratory diseases
by: Mohammed Al Ghobain, et al.
Published: (2025-01-01)

Development and evaluation of a recombinant monoclonal human antibody with virus-neutralizing activity against the F glycoprotein of respiratory syncytial virus
by: Sergey A. Klotchenko, et al.
Published: (2024-12-01)

Influenza D virus in cattle (review)
by: S. V. Koteneva, et al.
Published: (2024-03-01)

Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trialResearch in context
by: Gabriela Tapia-Calle, et al.
Published: (2025-01-01)